Why High-Flow Nasal Cannula Therapies are Growing in Popularity
The high-flow nasal cannula device can remain on the patient and offer continuous oxygen therapy, as well as possible positive pressure, even throughout the apneic interval.
Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Required for core site functionality, security and your session. Always active.
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
As per Cognitive Market Research's latest published report, the Global High flow Nasal Cannula market size was USD 19.69 Billion In 2022 and it is forecasted to reach USD 47.13 Billion By 2030. High flow Nasal Cannula Industry's Compound Annual Growth Rate will be 11.53 % from 2023 to 2030. Download a free sample with data verified by Supriya Yadav
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Component Segment | Air/Oxygen Blenders, Air Humidifiers, Single Heated Tubes, Nasal Cannulas, Others |
| Application Segment | Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Carbon Monoxide Toxicity, Bronchiectasis, Sleep Apnea, Others |
| End User Segment | Hospitals, Long-term Care Centers, Ambulatory Care Centers, Others |
|---|---|
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | xxxx | xxxx | xxxx | 11.53% |
| North America | xxxx | xxxx | xxxx | xxxx |
| United States | xxxx | xxxx | xxxx | xxxx |
| Canada | xxxx | xxxx | xxxx | xxxx |
| Mexico | xxxx | xxxx | xxxx | xxxx |
| Europe | xxxx | xxxx | xxxx | xxxx |
| United Kingdom | xxxx | xxxx | xxxx | xxxx |
| France | xxxx | xxxx | xxxx | xxxx |
| Germany | xxxx | xxxx | xxxx | xxxx |
| Italy | xxxx | xxxx | xxxx | xxxx |
| Russia | xxxx | xxxx | xxxx | xxxx |
| Spain | xxxx | xxxx | xxxx | xxxx |
| Sweden | xxxx | xxxx | xxxx | xxxx |
| Denmark | xxxx | xxxx | xxxx | xxxx |
| Switzerland | xxxx | xxxx | xxxx | xxxx |
| Luxembourg | xxxx | xxxx | xxxx | xxxx |
| Rest of Europe | xxxx | xxxx | xxxx | xxxx |
| Asia Pacific | xxxx | xxxx | xxxx | xxxx |
| China | xxxx | xxxx | xxxx | xxxx |
| Japan | xxxx | xxxx | xxxx | xxxx |
| South Korea | xxxx | xxxx | xxxx | xxxx |
| India | xxxx | xxxx | xxxx | xxxx |
| Australia | xxxx | xxxx | xxxx | xxxx |
| Singapore | xxxx | xxxx | xxxx | xxxx |
| Taiwan | xxxx | xxxx | xxxx | xxxx |
| South East Asia | xxxx | xxxx | xxxx | xxxx |
| Rest of APAC | xxxx | xxxx | xxxx | xxxx |
| South America | xxxx | xxxx | xxxx | xxxx |
| Brazil | xxxx | xxxx | xxxx | xxxx |
| Argentina | xxxx | xxxx | xxxx | xxxx |
| Colombia | xxxx | xxxx | xxxx | xxxx |
| Peru | xxxx | xxxx | xxxx | xxxx |
| Chile | xxxx | xxxx | xxxx | xxxx |
| Rest of South America | xxxx | xxxx | xxxx | xxxx |
| Middle East | xxxx | xxxx | xxxx | xxxx |
| Saudi Arabia | xxxx | xxxx | xxxx | xxxx |
| Turkey | xxxx | xxxx | xxxx | xxxx |
| UAE | xxxx | xxxx | xxxx | xxxx |
| Egypt | xxxx | xxxx | xxxx | xxxx |
| Qatar | xxxx | xxxx | xxxx | xxxx |
| Rest of Middle East | xxxx | xxxx | xxxx | xxxx |
| Africa | xxxx | xxxx | xxxx | xxxx |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | xxxx | xxxx | xxxx | xxxx |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →By Component, the Single Heated Tubes segment is expected to grow at a significant CAGR of High flow Nasal Cannula Market! The single-heated tube segment is expected to grow at a significant CAGR during the forecast period, as it is widely used in hospitals to provide respiratory support to patients with conditions such as acute respiratory disorders. A single heated tube is a type of medical device used to provide heated and humidified air to patients. It is typically used in conjunction with a mechanical ventilator or a high-flow nasal cannula system. Air/Oxygen Blenders Air Humidifiers Single Heated Tubes Nasal Cannulas Others
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The High flow Nasal Cannula Market Analysis market is highly competitive, with players expanding through new product launches, M&A, partnerships, and regulatory approvals for advanced technologies. The report covers financials (revenue, margin, market share 2021–2033) and SWOT analysis, while also highlighting company responses to tariff challenges via supply chain shifts, production changes, and digital healthcare investments.
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Fisher Paykel Healthcare Limited | ••• | ••• | ••• | ••• |
| ResMed Inc. | ••• | ••• | ••• | ••• |
| Becton | ••• | ••• | ••• | ••• |
| Smiths Medical | ••• | ••• | ••• | ••• |
| Great Group Medical Co. Ltd. | ••• | ••• | ••• | ••• |
| Hamilton Medical | ••• | ••• | ••• | ••• |
| MEK ICS CO. LTD. | ••• | ••• | ••• | ••• |
| Dickinson and Company | ••• | ••• | ••• | ••• |
| Vapotherm Inc. | ••• | ••• | ••• | ••• |
| Flexicare Medical Limited | ••• | ••• | ••• | ••• |
| Salter Labs | ••• | ••• | ••• | ••• |
| Teleflex Incorporated | ••• | ••• | ••• | ••• |
| TNI medical AG | ••• | ••• | ••• | ••• |
| Teijin Pharma Limited | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →As per Cognitive Market Research's latest published report, the Global High flow Nasal Cannula market size was USD 19.69 Billion In 2022 and it is forecasted to reach USD 47.13 Billion By 2030. High flow Nasal Cannula Industry's Compound Annual Growth Rate will be 11.53 % from 2023 to 2030
A high-flow nasal cannula (HFNC) is a new technology that delivers a high flow of warm, humidified gas. HFNC is easier to use and apply than non-invasive ventilation (NIV) and appears to be a good alternative treatment for hypoxic acute respiratory failure. It is a type of nasal cannula that provides a high flow rate of heated and humidified oxygen at a flow rate of up to 60 liters per minute.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The High flow Nasal Cannula Market Analysis is witnessing significant growth in the near future.
In 2023, the Air/Oxygen Blenders segment accounted for a notable share of the High flow Nasal Cannula Market Analysis.
★ Reviews
Rate this report
| Component | Air/Oxygen Blenders, Air Humidifiers, Single Heated Tubes, Nasal Cannulas, Others |
|---|---|
| Application | Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Carbon Monoxide Toxicity, Bronchiectasis, Sleep Apnea, Others |
| End User | Hospitals, Long-term Care Centers, Ambulatory Care Centers, Others |
| List of Competitors | Fisher Paykel Healthcare Limited, ResMed Inc., Becton, Smiths Medical, Great Group Medical Co. Ltd., Hamilton Medical, MEK ICS CO. LTD., Dickinson and Company, Vapotherm Inc., Flexicare Medical Limited, Salter Labs, Teleflex Incorporated, TNI medical AG, Teijin Pharma Limited |
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the High flow Nasal Cannula Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
The high-flow nasal cannula device can remain on the patient and offer continuous oxygen therapy, as well as possible positive pressure, even throughout the apneic interval.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the High flow Nasal Cannula Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the high flow nasal cannula market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.